The Urinary Disposition of Intravenously Administered 11-Nor-9-carboxy-delta-9-Tetrahydrocannabinol in Humans

@article{Dietz2007TheUD,
  title={The Urinary Disposition of Intravenously Administered 11-Nor-9-carboxy-delta-9-Tetrahydrocannabinol in Humans},
  author={L. Dietz and A. Glaz-Sandberg and H. Nguyen and G. Skopp and G. Mikus and R. Aderjan},
  journal={Therapeutic Drug Monitoring},
  year={2007},
  volume={29},
  pages={368-372}
}
  • L. Dietz, A. Glaz-Sandberg, +3 authors R. Aderjan
  • Published 2007
  • Chemistry, Medicine
  • Therapeutic Drug Monitoring
  • The objective of this study was to investigate the fraction of an administered dose of 11-nor-9-carboxy-delta-9-tetrahydrocannabinol (THCCOOH) that is actually excreted into urine and to determine its urinary half-life independent of the parent compound. Ten healthy, male marijuana nonusers who were enrolled in the study were administered a single dose of 5 mg THCCOOH by the intravenous route. Urine specimens were collected up to 96 hours after administration. Samples were extracted before and… CONTINUE READING
    13 Citations
    Cannabinoid concentrations in spot serum samples 24-48 hours after discontinuation of cannabis smoking.
    • 38
    • PDF

    References

    SHOWING 1-10 OF 49 REFERENCES
    Urinary excretion half-life of 11-nor-9-carboxy-delta9-tetrahydrocannabinol in humans.
    • 77
    The metabolism of delta 9-tetrahydrocannabinol and related cannabinoids in man.
    • 37
    Pharmacokinetics of delta 9-tetrahydrocannabinol in rabbits following single or multiple intravenous doses.
    • 48
    Tolerance and disposition of tetrahydrocannabinol in man.
    • C. A. Hunt, R. Jones
    • Chemistry, Medicine
    • The Journal of pharmacology and experimental therapeutics
    • 1980
    • 190
    • Highly Influential